ITCMDBv1
Clinical TrialID 436

Extract of Curcuma Longa Complexed With Phosphatidilcholine(Motore®)in the Treatment of Adults With Knee Osteoarthritis

NCT02409381

Osteoarthritis, Knee

Back to Browse

Relationship Network

Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.

Click a node to open it in a new tab
Trial: 1Herb: 1Links: 1
Arranging relationship network...

Record Fields

Scalar fields from the final clinical_trial record.

Clinical Trial Id
436
Evidence Id
436
Core Evidence Id
436
Source Clinical Trial Id
422
Herb2 Clinical Trial Id
HBCT000422
Nct Id
NCT02409381
Title
Extract of Curcuma Longa Complexed With Phosphatidilcholine(Motore®)in the Treatment of Adults With Knee Osteoarthritis
Status
Completed
Phase
Phase 4
Study Result
No
Study Condition
Osteoarthritis, Knee
Study Type
Interventional
Study Design
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Intervention
DRUG: Motore|DRUG: Alivium
Intervention Allocation
Randomized
Intervention Model
Parallel
Intervention Mask
Intervention Purpose
Treatment
Gender
All
Age
Adult, Older_Adult
Enrollment
288
Outcome Measure
Reduction in the pain domain score of the WOMAC questionnaire, The primary efficacy endpoint will be the reduction in the pain domain score of the WOMAC questionnaire after 42 (forty two) days of treatment, After 42 (forty two) days of treatment
Sponsor Collaborator
Ache Laboratorios Farmaceuticos S.A.
Funded By
INDUSTRY
Location
Ache Laboratorios Farmaceuticos, Guarulhos, São Paulo, Brazil
Other Id
ACH-MTR-04(02/13)
Start Date
2015-06
Primary Completion Date
2016-05
Completion Date
2016-06
First Posted
2015-04-06
Results First Posted
Last Update Posted
2016-08-25
Study Document
Study Url
https://clinicaltrials.gov/study/NCT02409381
Title Cn
Title En
Extract of Curcuma Longa Complexed With Phosphatidilcholine(Motore®)in the Treatment of Adults With Knee Osteoarthritis
Bilingual Status
semi_complete